The Cannabis Boomer's Daily Feed for January 13, 2026

The Cannabis Boomer's Daily Feed for January 13, 2026

Despite President Trump's recent executive order to reschedule cannabis, experts warn that it will do little to shield users from potential prosecution. The Department of Justice has already rescinded Biden-era guidance that directed U.S. attorneys to refrain from pursuing simple cannabis possession cases. Montana's legal marijuana industry has reached a major milestone, with over $1 billion in sales since the state legalized adult-use cannabis four years ago. The data shows a dramatic shift in consumer habits, as adult-use sales have surged while medical marijuana purchases have plummeted. As the new year begins, the push for marijuana legalization is gaining steam across the country. From the East Coast to the West, states are eyeing opportunities to enact both recreational and medical cannabis laws, bolstered by a recent federal move to reschedule the drug. This study explored adolescent attitudes towards cannabis use and how they relate to attitudes towards alcohol use. The key findings indicate that adolescents view cannabis use as more acceptable than alcohol use, and that they often use cannabis to cope with stress or social anxiety. This study examined the relationship between monthly simultaneous cannabis and alcohol use and mental health outcomes in male and female college students. The key findings were that simultaneous use was associated with higher levels of depression, anxiety, and stress, and these associations differed by sex, with stronger links observed in female students. This study examined the day-level effects of cannabis and alcohol use on sleep quality and duration among middle-aged and older adults in the community. The key findings suggest that cannabis use alone had negligible effects on sleep, but co-use of cannabis and alcohol attenuated the negative effects of alcohol on sleep. Visit The Cannabis Boomer Podcast homepage at https://www.cannabisboomer.com for in-depth interviews with leading cannabis researchers. #CannabisResearch #MarijuanaLegalization #AdolescentSubstanceUse #AlcoholAndCannabisCoUse #SleepQuality #CannabisScience #THC #CBD #OlderAdults #BabyBoomers

The Cannabis Boomer's Daily Feed for January 12, 2026

Massachusetts Moves Forward with Cannabis Cafes and Equity Initiatives The Massachusetts Cannabis Control Commission is ushering in a new era for the state's cannabis industry. With the recent legalization of social consumption, the commission is paving the way for cannabis cafes and lounges, providing new opportunities for social equity applicants disproportionately impacted by the war on drugs. Commission Chair Shannon O'Brien explains that these new licenses will be exclusively available to those who have been personally, or whose family members have been, affected by the criminalization of cannabis. The focus is on promoting public health and safety, with stringent regulations around ventilation and coordination with local officials. However, O'Brien acknowledges that the social equity program has yet to see the level of success they had hoped for, citing barriers to accessing capital as a key challenge. Seniors Embrace Cannabis as Pot Stocks Await Reclassification The senior population in the United States is increasingly turning to cannabis, with a 46% surge in usage reported. This trend coincides with President Trump's recent executive order to reclassify marijuana, a move that could have significant implications for the burgeoning cannabis industry. As the baby boomer generation ages, many are seeking alternative remedies to manage various health conditions. The appeal of cannabis, with its potential therapeutic benefits from compounds like CBD and THC, has resonated with this demographic. Experts suggest that seniors are drawn to cannabis as a natural solution for pain management, anxiety, and sleep issues, among other ailments. Marijuana Consumption Expands Across Massachusetts In a groundbreaking move, the Massachusetts Cannabis Control Commission has unanimously approved the expansion of on-site marijuana consumption in the state. This new regulation allows non-cannabis businesses, such as yoga studios and movie theaters, to obtain licenses to host consumption areas for adults aged 21 and over. Commission Chair Shannon O'Brien expressed that residents have been "eagerly" waiting for this opportunity to socially consume marijuana, and the new licenses will offer economic opportunities for small businesses and entrepreneurs. Neurocognitive outcomes in adolescents with and without four weeks of cannabis abstinence: a randomized clinical trial using contingency management. This study examined the neurocognitive effects of cannabis abstinence in adolescents. The key findings showed that adolescents who abstained from cannabis for four weeks exhibited improved neurocognitive performance compared to those who continued using cannabis. The study also found that contingency management was an effective intervention to promote cannabis abstinence. Cannabidiol reduces oxycodone self-administration while preserving its analgesic efficacy in a rat model of neuropathic pain. This study investigated the effects of CBD on oxycodone self-administration and hyperanalgesia in an animal model of chronic neuropathic pain. The key findings are that CBD reduced oxycodone self-administration in both sham and neuropathic pain rats, while the antinociceptive effects of oxycodone were preserved in the neuropathic pain group. Increasing use of cannabis edibles in response to recreational cannabis legalization in the United States. This study evaluated the associations between recreational cannabis legalization in the United States and primary mode of cannabis use, including smoking, eating/drinking, and vaporizing/dabbing. The key findings showed that the use of cannabis edibles increased significantly after recreational cannabis legalization, while the use of smoking and vaporizing/dabbing remained relatively stable. To hear in-depth interviews on these and other topics, go to The Cannabis Boomer Podcast homepage at https;//www.cannabisboomer.com #CannabisBoomer #CannabisNews #CannabisResearch #CannabisLegalization #CannabisEquity #CannabisEdibles #OpioidCrisis #NeurocognitiveEffects #CannabisAbstinence #CannabisConsumption

The Cannabis Boomer's Daily Feed for January 09, 2026

The state of Michigan is gearing up for a potential shakeup in the cannabis industry as a looming ban on high-THC hemp products could have significant implications for consumers. Industry experts warn that the ban could lead to a potential shortage of these unregulated products, potentially driving up prices or forcing consumers to seek alternatives, which may include turning to the licensed dispensaries. In a major development for the state's medical cannabis program, Kentucky Governor Andy Beshear has announced the first licensed medical cannabis processor in the Commonwealth. This marks a significant milestone for the state's medical cannabis program, which has faced some delays in getting off the ground. Beshear expressed his desire to see the program accelerate. As the use of medical cannabis continues to grow, healthcare providers are playing a crucial role in guiding patients through the complexities of this emerging field. Dr. Wen emphasizes the importance of healthcare providers taking the time to understand each patient's unique needs and medical history, and then providing personalized recommendations based on the available scientific evidence. Kentucky lawmakers have introduced a bill that would allow voters to decide the fate of recreational cannabis in the state. If approved, the bill would allow individuals to possess up to an ounce of cannabis and grow up to five plants for personal use. The proposed legislation aims to address the injustices of cannabis prohibition. A study found that a history of cannabis smoking was associated with a higher likelihood of subjective cognitive complaints, and this association was stronger among women with a longer duration of cannabis use. Another study suggests that medical cannabis may be a viable treatment option for individuals with depression, potentially offering an alternative or adjunct to traditional pharmacological interventions. A study comprehensively assessed the influence of adolescent cannabis use onset on neurocognitive trajectories and the impact of recent THC and CBD exposure. The findings highlight the potential detrimental effects of adolescent cannabis use on neurocognitive development. #CannabisResearch #MedicalCannabis #AdolescentCannabisUse #CognitiveFunction #Depression #KentuckyCannabis #MichiganCannabis #THC #CBD #BabyBoomers #OlderAdults

The Cannabis Boomer's Daily Feed for January 08, 2026

Cannabis Consumers Demand Equal Gun Rights After Rescheduling In a major victory for cannabis advocates, the federal government has reclassified marijuana from a Schedule One to a Schedule Three controlled substance. This move has prompted a prominent gun rights group to call for the restoration of firearm ownership rights for state-authorized cannabis consumers. Gun Owners of America, a leading pro-Second Amendment organization, is urging federal authorities to stop treating lawful cannabis users as "unlawful users of controlled substances" who are prohibited from possessing firearms. The group argues that with marijuana no longer classified as a dangerous, high-risk drug, there is no justification for denying gun rights to responsible cannabis consumers, particularly in states where the substance is legally regulated. Floridians Divided Over Proposed Cannabis Open-Container Law In a move that has sparked debate across the Sunshine State, a Florida lawmaker has introduced a bill that would ban the possession of open or ready-to-use cannabis products inside vehicles. The proposed legislation, known as the "Clear Minds, Safe Roads Act," aims to enhance road safety by mirroring the state's existing open-container laws for alcohol. Supporters of the bill argue that the measure is necessary to address the growing issue of impaired driving due to cannabis use, while critics are concerned about the potential impact on medical marijuana patients and the possibility of increased profiling. Cannabis involvement and mass shooting events in the United States from 1900 to 2019 This study examined the association between cannabis involvement and mass shootings in the United States from 1900 to 2019. The key findings indicate that a significant proportion of mass shooters had a history of cannabis use, and some had evidence of CBD or THC in their system at the time of the incident. However, the study has serious methodological flaws, as the authors do not show that shooters have a higher incidence of cannabis use than a demographically controlled population, and they do not acknowledge the length of time measurable cannabis can stay in the body long after use. Medical cannabis for chronic pain management: questions and answers between clinical and medico-legal issues This research article discusses the clinical and medico-legal aspects of using medical cannabis for chronic pain management. The key findings indicate that the efficacy of medical cannabis on pain reduction is statistically significant compared to placebo, with a mean reduction in the Numeric Rating Scale from baseline. While the incidence of serious adverse events was rare, medical cannabis may significantly increase AEs such as dizziness, tiredness, drowsiness, and nausea. Interactive associations of cannabis and alcohol outlet densities with assault injuries in California: a spatiotemporal analysis This study examined the impacts of recreational cannabis outlets on neighborhood-level assault injury rates in California and evaluated whether alcohol outlet density moderated these associations. The key findings were that the introduction of recreational cannabis outlets may have contributed to a small increase in nonfirearm assault injuries, but there was no association with firearm assault injuries. A hypothetical 20 percent reduction in alcohol outlet densities was associated with fewer firearm and nonfirearm assault injuries. #Cannabis #GunRights #Florida #MassShootings #ChronicPain #AssaultInjuries #AlcoholOutlets #CannabisOutlets #THC #CBD #OlderAdults #BabyBoomers

The Cannabis Boomer's Daily Feed for January 07, 2026

On today's Cannabis Boomer's Journal of News and Reviews in Cannabis Science, Dr. Alex Terrazas PhD gives his take on the latest findings in cannabis research. Florida Moves to Restrict Medical Marijuana Use in Vehicles A new bill has been introduced in the Florida Senate that aims to crack down on the transportation of open cannabis products. The proposed legislation would make it illegal for both drivers and passengers to have open containers of medical marijuana, hemp, or THC-infused products in their vehicles. Patient advocates warn that it could create significant hardships for the state's nearly 1 million registered medical marijuana users. DEA Delays Cannabis Rescheduling Decision Despite Executive Order The Drug Enforcement Administration has confirmed that the process to reschedule cannabis remains in limbo, despite a recent executive order from President Trump directing the attorney general to complete the reform "in the most expeditious manner." The delay stands in contrast to the DEA's moves to increase production quotas for psychedelics like psilocybin and DMT. Delaware Decriminalizes Public Marijuana Smoking The state of Delaware has passed a bill that decriminalizes the public consumption of marijuana. Individuals caught smoking marijuana in public will face a civil fine of $100, rather than criminal charges. Supporters of the bill argue that this move will help address racial disparities in marijuana-related arrests and destigmatize the use of the drug. Real-world efficacy and safety of CBD in developmental and epileptic encephalopathies This study found that CBD was effective in reducing seizure frequency across various developmental and epileptic encephalopathies, including off-label indications, and was generally well-tolerated, with adverse events being mostly mild to moderate in severity. Rethinking Alzheimer's: Harnessing CBD to Modulate I D O and c GAS Pathways for Neuroinflammation Control This study investigated how CBD independently influences two key neuroinflammatory regulators in Alzheimer's disease. The findings support CBD as a potential monotherapy or adjunctive treatment for Alzheimer's Disease by targeting distinct neuroinflammatory pathways. CBD as a multifaceted therapeutic agent: mitigating Alzheimer's disease pathology and enhancing cognitive function This research article explores the potential of CBD as a therapeutic agent for Alzheimer's disease, focusing on its ability to mitigate disease pathology and enhance cognitive function. The key findings indicate that CBD exhibits neuroprotective effects, reduces neuroinflammation, and improves cognitive performance in Alzheimer's disease models. #CannabisBoomer #THC #CBD #CannabisScience #MedicalMarijuana #Alzheimer'sDisease #Epilepsy #CBD #DEA #Rescheduling #PublicConsumption #Florida #Delaware #Research #Science #BabyBoomers #OlderAdults